Pinal lab:Biokorf: Difference between revisions
mNo edit summary |
mNo edit summary |
||
| Line 1: | Line 1: | ||
{{Template:Pinal lab}} | {{Template:Pinal lab}} | ||
<div style="padding: 10px; width: 720px; height: | <div style="padding: 10px; width: 720px; height: 130px; border: 5px solid #CC9933;"> | ||
<p>Dr. Rodolfo Pinal's [http://otc-prf.org/sites/default/files/pinal.jpg Biokorf, LLC], is creating prefabricated drug dosages that could be used by compounding pharmacists to support patient-centered, precision medicine (PCPM). The company’s technology makes pharmaceutical dosage forms in modular form from prefabricated components. The “pills” are patient-tailored in size and shape, with the precise dose and drug release characteristics that the physician prescribes for the individual patient. The Purdue Office of Technology Commercialization and Purdue Foundry have supported Biokorf officials throughout the process to translate the Purdue technology into a startup. <em>[http://otc-prf.org/news/purdue-based-pharmaceutical-startup-creates-prefabricated-drug-dosages-support-patient-centric- Read more]</em></p> | <p>Dr. Rodolfo Pinal's [http://otc-prf.org/sites/default/files/pinal.jpg Biokorf, LLC], is creating prefabricated drug dosages that could be used by compounding pharmacists to support patient-centered, precision medicine (PCPM). The company’s technology makes pharmaceutical dosage forms in modular form from prefabricated components. The “pills” are patient-tailored in size and shape, with the precise dose and drug release characteristics that the physician prescribes for the individual patient. The Purdue Office of Technology Commercialization and Purdue Foundry have supported Biokorf officials throughout the process to translate the Purdue technology into a startup. <em>[http://otc-prf.org/news/purdue-based-pharmaceutical-startup-creates-prefabricated-drug-dosages-support-patient-centric- Read more]</em></p> | ||
Revision as of 08:37, 17 December 2014
Dr. Rodolfo Pinal's Biokorf, LLC, is creating prefabricated drug dosages that could be used by compounding pharmacists to support patient-centered, precision medicine (PCPM). The company’s technology makes pharmaceutical dosage forms in modular form from prefabricated components. The “pills” are patient-tailored in size and shape, with the precise dose and drug release characteristics that the physician prescribes for the individual patient. The Purdue Office of Technology Commercialization and Purdue Foundry have supported Biokorf officials throughout the process to translate the Purdue technology into a startup. Read more
<html>Hosted by <a href="http://www.openwetware.org"><img src="http://openwetware.org/images/0/01/80x15_openwetware.png" border="0" /></a></right> </html>
